Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy

Chia-Chen Hsu,Yu-Fu Su,Kuo-Yang Tsai,Feng-Chih Kuo,Chi-Fu Chiang,Chu-Yen Chien,Ying-Chen Chen,Chien-Hsing Lee,Yu-Chiao Wu,Kun Wang,Shyun-Yeu Liu,Yi-Shing Shieh
DOI: https://doi.org/10.1186/s12935-020-01401-w
IF: 6.429
2020-07-10
Cancer Cell International
Abstract:Abstract Background The mechanisms of neuronal protein γ-synuclein (SNCG) in the malignancy of oral squamous cell carcinoma (OSCC) are not clear. This study tested the hypothesis that SNCG is involved in nicotine-induced malignant behaviors of OSCC. The effect of nicotine on SNCG expression and epithelial-to-mesenchymal transition (EMT) markers were examined. Methods Short hairpin RNA (shRNA) and an antagonist specific for α7-nicotine acetylcholine receptors (α7-nAChRs) were used to examine the role of α7-nAChRs in mediating the effects of nicotine. Knockdown of SNCG in nicotine-treated cells was performed to investigate the role of SNCG in cancer malignancy. The in vivo effect of nicotine was examined using a nude mouse xenotransplantation model. Results Nicotine increased SNCG expression in a time- and dose-dependent manner. Nicotine treatment also increased E-cadherin and ZO-1 and decreased fibronectin and vimentin expression. After specific knockdown of α7-nAChRs and inhibition of the PI3/AKT signal, the effect of nicotine on SNCG expression was attenuated. Silencing of SNCG abolished nicotine-induced invasion and migration of OSCC cells. The xenotransplantation model revealed that nicotine augmented tumor growth and SNCG expression. Conclusion Nicotine upregulated SNCG expression by activating the α7-nAChRs/PI3/AKT signaling that are participated in nicotine-induced oral cancer malignancy.
oncology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the mechanism of action of γ - synuclein (SNCG) in the malignant behavior of oral squamous cell carcinoma (OSCC) induced by nicotine. Specifically, the researchers hypothesized that SNCG is involved in the OSCC malignant behavior caused by nicotine and verified this hypothesis through experiments. The paper mainly discusses the following aspects: 1. **The influence of nicotine on SNCG expression**: - The study found that nicotine can increase the expression of SNCG in OSCC cells in a time - and dose - dependent manner. - Nicotine treatment also increased the expression of epithelial markers E - cadherin and ZO - 1, while reducing the expression of mesenchymal markers fibronectin and vimentin, indicating that nicotine may induce epithelial - mesenchymal transition (EMT). 2. **The role of α7 - nicotinic acetylcholine receptor (α7 - nAChRs)**: - Short hairpin RNA (shRNA) and the specific antagonist methyllycaconitine (MLA) of α7 - nAChRs were used to study the role of α7 - nAChRs in the nicotine effect. - The results showed that knocking down or inhibiting α7 - nAChRs can attenuate the promoting effect of nicotine on SNCG expression. 3. **The involvement of the PI3K/AKT signaling pathway**: - The study found that nicotine up - regulates the expression of SNCG by activating the α7 - nAChRs/PI3K/AKT signaling pathway. - Inhibiting the PI3K/AKT signaling pathway can significantly reduce the promoting effect of nicotine on SNCG expression. 4. **The role of SNCG in nicotine - induced malignant behavior**: - Knocking down SNCG can significantly inhibit the migration and invasion ability of OSCC cells induced by nicotine. - In vivo experiments (nude mouse xenograft model) further confirmed that nicotine can promote tumor growth and SNCG expression. In summary, the main purpose of this paper is to reveal the molecular mechanism by which nicotine up - regulates SNCG expression through the α7 - nAChRs/PI3K/AKT signaling pathway, thereby participating in the malignant behavior of OSCC. These findings provide new insights into understanding the role of nicotine in the progression of oral cancer and may provide a theoretical basis for the development of oral cancer treatment strategies for smoking patients.